Role of inflammation in endophthalmitis

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Vallejo Garcia, J L ^a   Asencio Duran, M ^b   Pastora Salvador, N ^b   Vinciguerra, P ^a   Romano, M R ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA CRYSTALLIN; CEFTAZIDIME; CORTICOSTEROID; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; GROWTH FACTOR; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; PREDNISONE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN;

ANTIBIOTIC THERAPY; APOPTOSIS; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CATARACT EXTRACTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; ELECTRORETINOGRAPHY; ENDOPHTHALMITIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA CELL; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY; ANIMAL; DRUG EFFECT; IMMUNOLOGY; METABOLISM;

ANIMALS; APOPTOSIS; ENDOPHTHALMITIS; HUMANS; INFLAMMATION;

EID: 84867751631     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/196094     Document Type: Review

References (48)

1. Results of the endophthalmitis vitrectomy study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Archives of Ophthalmology 1995 113 12 1479 1496 2-s2.0-0028839594
2. Verbraeken H., Treatment of postoperative endophthalmitis. Ophthalmologica 1995 209 3 165 171 2-s2.0-0028924190
3. Taban M., Behrens A., Newcomb R. L., Nobe M. Y., Saedi G., Sweet P. M., McDonnell P. J., Acute endophthalmitis following cataract surgery: a systematic review of the literature. Archives of Ophthalmology 2005 123 5 613 620 2-s2.0-18444400831 10.1001/archopht.123.5.613 (Pubitemid 40695508)
4. Cooper B. A., Holekamp N. M., Bohigian G., Thompson P. A., Case-control study of endophthalmitis after cataract surgery comparing scleral tunnel and clear corneal wounds. American Journal of Ophthalmology 2003 136 2 300 305 2-s2.0-0041848365 10.1016/S0002-9394(03)00202-2 (Pubitemid 36904078)
5. Ramappa M., Majji A. B., Murthy S. I., An outbreak of acute post-cataract surgery Pseudomonas sp. endophthalmitis caused by contaminated hydrophilic intraocular lens solution. Ophthalmology 2012 119 3 564 570
6. Boks T., Van Dissel J. T., Teterissa N., Ros F., Mahmut M. H., Utama E. D., Rol M., Van Asdonk P., Airiani S., Van Meurs J. C., An outbreak of endophthalmitis after extracapsular cataract surgery probably caused by endotoxin contaminated distilled water used to dissolve acetylcholine. British Journal of Ophthalmology 2006 90 9 1094 1097 2-s2.0-33748442103 10.1136/bjo.2006.094060 (Pubitemid 44351135)
7. Pijl B. J., Theelen T., Tilanus M. A. D., Rentenaar R., Crama N., Acute endophthalmitis after cataract surgery: 250 consecutive cases treated at a tertiary referral center in the Netherlands. American Journal of Ophthalmology 2010 149 3 482.e2 487.e2 2-s2.0-76749122794 10.1016/j.ajo.2009.09.021
8. Callegan M. C., Booth M. C., Jett B. D., Gilmore M. S., Pathogenesis of gram-positive bacterial endophthalmitis. Infection and Immunity 1999 67 7 3348 3356 2-s2.0-0032968218 (Pubitemid 29291502)
9. Howes E. L. Jr., Cole P. W., Adair T. M., Cruse V. K., Pollycove M., Cellular and vascular responses in acute experimental ocular inflammation. Investigative Ophthalmology and Visual Science 1994 35 12 4031 4038 2-s2.0-0027962684 (Pubitemid 24350667)
10. Rosenbaum J. T., Rosenzweig H. L., Smith J. R., Martin T. M., Planck S. R., Uveitis secondary to bacterial products. Ophthalmic Research 2008 40 3-4 165 168 2-s2.0-42449160656 10.1159/000119870 (Pubitemid 351562897)
11. Streilein J. W., Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. Journal of Leukocyte Biology 2003 74 2 179 185 2-s2.0-0041850024 10.1189/jlb.1102574 (Pubitemid 38040414)
12. Taylor A. W., Ocular immune privilege. Eye 2009 23 10 1885 1889 2-s2.0-70350158502 10.1038/eye.2008.382
13. Apte R. S., Sinha D., Mayhew E., Wistow G. J., Niederkorn J. Y., Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. Journal of Immunology 1998 160 12 5693 5696 2-s2.0-0032526635 (Pubitemid 28298023)
14. Kumar A., Shamsuddin N., Retinal Muller glia initiate innate response to infectious stimuli via toll-like receptor signaling. PLoS ONE 2012 7 1 e29830
15. Novosad B. D., Astley R. A., Callegan M. C., Role of Toll-like receptor (TLR) 2 in experimental Bacillus cereus endophthalmitis. PLoS ONE 2011 6 12 e28619
16. Chang J. H., McCluskey P. J., Wakefield D., Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. British Journal of Ophthalmology 2006 90 1 103 108 2-s2.0-29744452892 10.1136/bjo.2005.072686 (Pubitemid 43029907)
17. Kochan T., Singla A., Tosi J., Toll-like receptor 2 ligand pretreatment attenuates retinal microglial inflammatory response but enhances phagocytic activity toward Staphylococcus aureus. Infection and Immunity 2012 6 2076 2088
18. Kumar A., Singh C. N., Glybina I. V., Mahmoud T. H., Yu F. S. X., Toll-like receptor 2 ligand-induced protection against bacterial endophthalmitis. Journal of Infectious Diseases 2010 201 2 255 263 2-s2.0-75649084602 10.1086/649589
19. Petropoulos I. K., Vantzou C. V., Lamari F. N., Karamanos N. K., Anastassiou E. D., Pharmakakis N. M., Expression of TNF- α IL-1 β and IFN- γ in Staphylococcus epidermidis slime-positive experimental endophthalmitis is closely related to clinical inflammatory scores. Graefe's Archive for Clinical and Experimental Ophthalmology 2006 244 10 1322 1328 2-s2.0-33749049360 10.1007/s00417-006-0261-2 (Pubitemid 44463472)
20. Pollreisz A., Rafferty B., Kozarov E., Klebsiella pneumoniae induces an inflammatory response in human retinal-pigmented epithelial cells. Biochemical and Biophysical Research Communications 2012 418 1 33 37
21. Rosenbaum J. T., Boney R. S., Activity of an interleukin 1 receptor antagonist in rabbit models of uveitis. Archives of Ophthalmology 1992 110 4 547 549 2-s2.0-0026552420
22. Rosenbaum J. T., Boney R. S., Failure to inhibit endotoxin-induced uveitis with antibodies that neutralize tumor necrosis factor. Regional Immunology 1993 5 5 299 303 2-s2.0-0027892130 (Pubitemid 24095095)
23. Brito B. E., O'Rourke L. M., Pan Y., Anglin J., Planck S. R., Rosenbaum J. T., IL-1 and TNF receptor-deficient mice show decreased inflammation in an immune complex model of uveitis. Investigative Ophthalmology and Visual Science 1999 40 11 2583 2589 2-s2.0-0032868150 (Pubitemid 29455487)
24. Ramadan R. T., Moyer A. L., Callegan M. C., A role for tumor necrosis factor- α in experimental Bacillus cereus endophthalmitis pathogenesis. Investigative Ophthalmology and Visual Science 2008 49 10 4482 4489 2-s2.0-53449102895 10.1167/iovs.08-2085
25. Arimura N., Ki-i Y., Hashiguchi T., Sakamoto T., Maruyama I., High-mobility group box 1 protein in endophthalmitis. Graefe's Archive for Clinical and Experimental Ophthalmology 2008 246 7 1053 1058 2-s2.0-44649157587 10.1007/s00417-008-0827-2
26. Watanabe T., Keino H., Sato Y., Kudo A., Kawakami H., Okada A. A., High mobility group box protein-1 in experimental autoimmune uveoretinitis. Investigative Ophthalmology and Visual Science 2009 50 5 2283 2290 2-s2.0-65549132946 10.1167/iovs.08-2709
27. Lotze M. T., Tracey K. J., High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nature Reviews Immunology 2005 5 4 331 342 2-s2.0-17144376810 10.1038/nri1594 (Pubitemid 40516158)
28. Yang H., Ochani M., Li J., Qiang X., Tanovic M., Harris H. E., Susarla S. M., Ulloa L., Wang H., DiRaimo R., Czura C. J., Wang H., Roth J., Warren H. S., Fink M. P., Fenton M. J., Andersson U., Tracey K. J., Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proceedings of the National Academy of Sciences of the United States of America 2004 101 1 296 301 2-s2.0-9144241208 10.1073/pnas.2434651100 (Pubitemid 38084244)
29. Zhang Y., Cho C. H., Atchaneeyasakul L. O., McFarland T., Appukuttan B., Stout J. T., Activation of the mitochondrial apoptotic pathway in a rat model of central retinal artery occlusion. Investigative Ophthalmology and Visual Science 2005 46 6 2133 2139 2-s2.0-22144435950 10.1167/iovs.04-1235
30. Popov S. G., Villasmil R., Bernardi J., Grene E., Cardwell J., Wu A., Alibek D., Bailey C., Alibek K., Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochemical and Biophysical Research Communications 2002 293 1 349 355 2-s2.0-0036295213 10.1016/S0006-291X(02)00227-9 (Pubitemid 34694214)
31. Pharmakakis N. M., Petropoulos I. K., Georgakopoulos C. D., Vantzou C. V., Anastassiou E. D., Mavropoulos A., Zolota V., Apoptotic mechanisms within the retina in Staphylococcus epidermidis experimental endophthalmitis. Graefe's Archive for Clinical and Experimental Ophthalmology 2009 247 5 667 674 2-s2.0-64449084175 10.1007/s00417-008-0996-z
32. Engelbert M., Gilmore M. S., Fas ligand but not complement is critical for control of experimental Staphylococcus aureus endophthalmitis. Investigative Ophthalmology and Visual Science 2005 46 7 2479 2486 2-s2.0-23244444708 10.1167/iovs.04-1139 (Pubitemid 43119497)
33. Griffith T. S., Brunner T., Fletcher S. M., Green D. R., Ferguson T. A., Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995 270 5239 1189 1192 2-s2.0-0028879109
34. Minami M., Mizutani T., Kawanishi R., Suzuki Y., Mori H., Neuronal expression of α B crystallin in cerebral infarction. Acta Neuropathologica 2003 105 6 549 554 2-s2.0-0038790011 (Pubitemid 36798854)
35. Ray P. S., Martin J. L., Swanson E. A., Otani H., Dillmann W. H., Das D. K., Transgene overexpression of α B crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion. FASEB Journal 2001 15 2 393 402 2-s2.0-0035124724 10.1096/fj.00-0199com (Pubitemid 32141431)
36. Parcellier A., Schmitt E., Brunet M., Hammann A., Solary E., Garrido C., Small heat shock proteins HSP27 and α B-crystallin: cytoprotective and oncogenic functions. Antioxidants and Redox Signaling 2005 7 3-4 404 413 2-s2.0-14044272999 10.1089/ars.2005.7.404 (Pubitemid 40279808)
37. Xi J., Farjo R., Yoshida S., Kern T. S., Swaroop A., Andley U. P., A comprehensive analysis of the expression of crystallins in mouse retina. Molecular Vision 2003 9 410 419 2-s2.0-0142056039 (Pubitemid 38104819)
38. Yaung J., Jin M., Barron E., Spee C., Wawrousek E. F., Kannan R., Hinton D. R., α -Crystallin distribution in retinal pigment epithelium and effect of gene knockouts on sensitivity to oxidative stress. Molecular Vision 2007 13 566 557 2-s2.0-34147145520 (Pubitemid 46561918)
39. Whiston E. A., Sugi N., Kamradt M. C., Sack C., Heimer S. R., Engelbert M., Wawrousek E. F., Gilmore M. S., Ksander B. R., Gregory M. S., α B-crystallin protects retinal tissue during Staphylococcus aureus -induced endophthalmitis. Infection and Immunity 2008 76 4 1781 1790 2-s2.0-42149127827 10.1128/IAI.01285-07 (Pubitemid 351562024)
40. Das T., Jalali S., Gothwal V. K., Sharrna S., Naduvilath T. J., Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study. British Journal of Ophthalmology 1999 83 9 1050 1055 2-s2.0-0032825263 (Pubitemid 29433428)
41. Albrecht E., Richards J. C., Pollock T., Cook C., Myers L., Adjunctive use of intravitreal dexamethasone in presumed bacterial endophthalmitis: a randomised trial. British Journal of Ophthalmology 2011 95 1385 1388 2-s2.0-79251601929 10.1136/bjo.2010.187963
42. Gan I. M., Ugahary L. C., van Dissel J. T., Feron E., Peperkamp E., Veckeneer M., Mulder P. G. H., Platenkamp G. J., van Meurs J. C., Intravitreal dexamethasone as adjuvant in the treatment of postoperative endophthalmitis: a prospective randomized trial. Graefe's Archive for Clinical and Experimental Ophthalmology 2005 243 12 1200 1205 2-s2.0-30344482540 10.1007/s00417-005-0133-1 (Pubitemid 43055182)
43. Shah G. K., Stein J. D., Sharma S., Sivalingam A., Benson W. E., Regillo C. D., Brown G. C., Tasman W., Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis. Ophthalmology 2000 107 3 486 489 2-s2.0-0034077253 10.1016/S0161-6420(99)00139-6 (Pubitemid 30191369)
44. Hall E. F., Scott G. R., Musch D. C., Adjunctive intravitreal dexamethasone in the treatment of acute endophthalmitis following cataract surgery. Journal of Clinical Ophthalmology 2008 2 1 139 145
45. De Kaspar H. M., Ta C. N., Engelbert M., Mette M., Thiel M., Kampik A., Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus -induced experimental endophthalmitis. Retina 2008 28 2 326 332 2-s2.0-42449162428 10.1097/IAE.0b013e3181237cf8 (Pubitemid 351643165)
46. Liu S. M., Way T., Rodrigues M., Steidl S. M., Effects of intravitreal corticosteroids in the treatment of Bacillus cereus endophthalmitis. Archives of Ophthalmology 2000 118 6 803 806 2-s2.0-0034096952 (Pubitemid 30395178)
47. Ermis S. S., Cetinkaya Z., Kiyici H., Ozturk F., Treatment of Staphylococcus epidermidis endophthalmitis with intravitreal moxifloxacin in a rabbit model. Tohoku Journal of Experimental Medicine 2005 205 3 223 229 2-s2.0-17844374114 10.1620/tjem.205.223 (Pubitemid 40584890)
48. Pollack J. S., Beecher D. J., Pulido J. S., Wong A. C. L., Failure of intravitreal dexamethasone to diminish inflammation or retinal toxicity in an experimental model of Bacillus cereus endophthalmitis. Current Eye Research 2004 29 4-5 253 259 2-s2.0-11844277673 10.1080/02713680490516701 (Pubitemid 40095008)